Vytrus Biotech S.A. (VYT) — Strategic Asset Allocation Index
Vytrus Biotech S.A. (VYT) has a Strategic Asset Allocation Index of 21.6% as of December 2022. Strategic assets (PP&E of €1.03 Million plus long-term investments of €-) total €1.03 Million, measured against net assets of €4.75 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Vytrus Biotech S.A. Strategic Asset Allocation Index (2020–2022)
This chart shows how Vytrus Biotech S.A.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 21.6%, representing strategic assets of €1.03 Million against net assets of €4.75 Million EUR. Explore cash flow conversion of Vytrus Biotech S.A. to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Vytrus Biotech S.A. (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Vytrus Biotech S.A. from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Vytrus Biotech S.A. stock valuation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 21.6% | €1.03 Million | €1.03 Million | €- | €4.75 Million | ▲ +5.6 pp |
| 2021 | 16.0% | €678.42K | €678.42K | €- | €4.25 Million | ▲ +0.0 pp |
| 2020 | 15.9% | €574.73K | €574.73K | €- | €3.61 Million | — |